End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
1,045 PHP | -1.42% |
|
-1.88% | -3.24% |
06-04 | Acen Corporation Eyes $6 Billion Equity Capital for Expansion | CI |
04-24 | Acen Corporation Announces Board and Committee Changes | CI |
Summary
- From a short-term investment perspective, the company presents a deteriorated fundamental situation
Strengths
- The company's EBITDA/Sales ratio is relatively high and results in high margins before depreciation, amortization and taxes.
- The group's activity appears highly profitable thanks to its outperforming net margins.
- The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
Weaknesses
- One of the major weak points of the company is its financial situation.
- The company's "enterprise value to sales" ratio is among the highest in the world.
- The firm pays small or no dividend to shareholders. For that reason, it is not a yield company.
- For the last four months, the sales outlook for the coming years has been revised downwards. No recovery of the group's activities is yet foreseen.
- For the past year, analysts have significantly revised downwards their profit estimates.
- For the last four months, earnings estimated by analysts have been revised downwards with respect to the next two years.
- Over the past twelve months, analysts' opinions have been revised negatively.
- Prospects from analysts covering the stock are not consistent. Such dispersed sales estimates confirm the poor visibility into the group's activity.
- The price targets of various analysts who make up the consensus differ significantly. This reflects different assessments and/or a difficulty in valuing the company.
Ratings chart - Surperformance
Sector: Independent Power Producers
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-3.24% | 3.13B | - | ||
+16.58% | 41.74B | B | ||
+40.62% | 33.86B | - | C | |
+35.05% | 18.27B | B- | ||
+53.77% | 14.76B | B | ||
+36.02% | 8.97B | C+ | ||
+86.11% | 6.97B | D- | ||
+35.77% | 6.37B | C+ | ||
+39.01% | 5.28B | C | ||
+38.81% | 4.05B | - |
Financials
Valuation
Momentum
Consensus
Business Predictability
- Stock Market
- Equities
- ACEN Stock
- ACENB Stock
- Ratings Acen Corporation